New Zealand on Monday announced it had recorded its first death linked to Pfizer’s COVID-19 vaccine after a woman suffered from myocarditis, which is known to be a rare side effect of inflammation in the heart muscle.
New Zealand’s COVID-19 Vaccine Independent Safety Monitoring Board (CV-ISMB) released a statement on Monday advising health care professionals and consumers to be aware of myocarditis and pericarditis, another rare side effect that can occur after vaccine administration.
“The CV-ISMB extends their sympathies to the woman’s family and friends during this difficult time and thanks the family for their assistance with this investigation,” the New Zealand Ministry of Health said in a statement.
